- C-CDA Scorecard Now Available
- Data Update: EHR Products Used for MU Attestation Public Use File
- New Tools, Data Set Available: Health IT News
- Federal Advisory Committee Schedule July 3 - July 9
A beta version Consolidated Clinical Document Architecture (C-CDA) scorecard is now available on ONC’s Standards Implementation & Testing Environment (SITE). The SITE C-CDA Scorecard is a benchmarking tool designed to enable health care providers, health IT implementers, and health IT developers compare how the C-CDAs created by their health IT stack up against the HL7 C-CDA implementation guide and HL7 best practices.
The SITE C-CDA Scorecard and its scoring methodology is one aspect of the cooperative agreement between ONC and HL7. It includes three layers of review: 1) 2014 Edition and 2015 Edition health IT certification requirements (as applicable); 2) HL7 C-CDA implementation guide specifications (for C-CDA 2.1 in the beta version, and R1.1 later); and 3) authoritative implementation “best practices” published by HL7 for C-CDA. The scorecard produces a categorized report with C-CDA section grades and tips related to areas for improvement.
ONC's SITE (HealthIT.gov/SITE) is a centralized collection of testing tools and resources. SITE is designed to assist health IT developers and health IT users evaluate technical standards and maximize the potential of their health IT implementations.
For inquiries or questions, please email ONC TechLab.
ONC updated the EHR Products Used for MU Attestation Public Use File (PUF) with Medicare EHR Incentive Program data through April 2016. The PUF contains a time series of all eligible hospital and professional attestations through the Medicare EHR Incentive Program and the certified health IT products reported by those providers for each year. The dataset is available in open format with complete documentation and explanation of the data through the HealthIT.gov Dashboard. Download the data now!
The National Cancer Institute has opened a funding opportunity to advance surveillance science by developing new and innovative tools and methods for more efficient, detailed, timely and accurate data collection by population-based cancer registries in the U.S. This is a five-year, two-phase program for investigators that partner with a minimum of two U.S. population-based cancer registries. For more information please contact Nadia Howlader.
No Federal Advisory Committee meetings are scheduled July 3 - 9.